WebDec 18, 2014 · For information about your submission, including status and tracking enquiries, contact the clinical trials helpline on 020 3080 6456 (Monday to Friday 8:30am … WebClinical Trial Protocol . Trial Title: INTERIM: a randomised phase II feasibility study of ... EudraCT number: 2016-005228-27 IRAS ID Number: 213113 Page 2 of 74 INTERIM Protocol Version: V1.1 Version Date: 21 September 2024 1 Protocol Signatures: I give my approval for the attached protocol entitled INTERIM: a randomised phase II ...
Research registration and research project identifiers
WebMar 31, 2024 · Each patient was assigned a trial number and a list of trial numbers was sent to the Clinical Trials Unit for sampling. ... was approved on 16th October 2024 by the National Health Service Research Ethics Committee (REC reference: 18/LO/1354; IRAS project ID: 229210). Protection of participants and researchers from harm was paramount … WebThe Integrated Research Application System (IRAS) is a single system for applying for the permissions and approvals for health and social / community care research in the UK. … daughter of mick jagger crossword
IRAS Help - Preparing & submitting applications - Site specific information
WebMay 23, 2024 · ISRCTN registration provides the unique identification number necessary for the future publication of clinical trials and other studies. You could qualify for free ISRCTN registration from the Department of Health and Social Care (DHSC) if your non-commercial study is included on the NIHR CRN Portfolio.. Research transparency is important in … WebFeb 12, 2024 · Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04752332 Locations Show 177 study locations Sponsors and Collaborators Eli Lilly and Company Investigators More Information Go to Additional Information: A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast … WebFederal Register, Evaluating Inclusion and Exclusion Criteria in Clinical Trials; Public Meeting (Docket number: FDA-2024-N-0129), 1 ... over age 65 in clinical trials, it can be challenging to determine the strength and generalizability of the evidence for the Medicare population. Since the early 1980s, FDA has developed guidance (inalized in ... daughter of melai